GPT and Hepatic fibrosis: For instance, a randomized, double-blind, placebo-controlled study conducted in Taiwan, China showed that tenofovir disoproxil fumarate could reduce the risk of liver fibrosis in patients with non-cirrhotic CHB and minimally raised ALT [126].